Search

Your search keyword '"Gori, Stefania"' showing total 1,269 results

Search Constraints

Start Over You searched for: Author "Gori, Stefania" Remove constraint Author: "Gori, Stefania"
1,269 results on '"Gori, Stefania"'

Search Results

1. Majorana phases beyond neutrinoless double beta decay

2. Diphoton Signals of Muon-philic Scalars at DarkQuest

3. ACE Science Workshop Report

4. Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM)

5. QCD Axion-Mediated Dark Matter

6. Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients

8. UV physics from IR features: new prospects from top flavor violation

9. Sensitivity of Spin-Precession Axion Experiments

10. Snowmass 2021 Dark Matter Complementarity Report

11. On the Sensitivity of Spin-Precession Axion Experiments

12. Snowmass 2021 Cross Frontier Report: Dark Matter Complementarity (Extended Version)

13. Dark Sector Physics at High-Intensity Experiments

14. New Opportunities for Detecting Axion-Lepton Interactions

15. Heavy Neutral Leptons at Beam Dump Experiments of Future Lepton Colliders

16. Experiments and Facilities for Accelerator-Based Dark Sector Searches

17. New physics searches at kaon and hyperon factories

18. DarkQuest: A dark sector upgrade to SpinQuest at the 120 GeV Fermilab Main Injector

19. The International Linear Collider: Report to Snowmass 2021

20. Physics Opportunities for the Fermilab Booster Replacement

21. Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review

22. New Physics Searches at Kaon and Hyperon Factories

24. Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project

25. Exotic Higgs Decays

26. Dark Matter Freeze-In with a Heavy Mediator: Beyond the EFT Approach

28. Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group

29. Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group

30. Explaining $(g-2)_{\mu}$ with Multi-TeV Sleptons

31. Feebly-Interacting Particles:FIPs 2020 Workshop Report

32. Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program

33. Electron EDM in the complex two-Higgs doublet model

34. Dark Scalars and Heavy Neutral Leptons at DarkQuest

35. ILC Study Questions for Snowmass 2021

36. KOTO vs. NA62 Dark Scalar Searches

37. Reinterpretation of LHC Results for New Physics: Status and Recommendations after Run 2

38. Implications for Electric Dipole Moments of a Leptoquark Scenario for the $B$-Physics Anomalies

40. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

41. Light Dark Matter from Entropy Dilution

42. Constraining axion-like particles from rare pion decays

43. Neutrino Tridents at DUNE

44. Constraining axionlike particles from rare pion decays

45. LHC Dark Matter Working Group: Next-generation spin-0 dark matter models

46. The second Higgs at the lifetime frontier

47. Wobbly Dark Matter Signals at Cherenkov Telescopes from Long Lived Mediator Decays

48. Recommendations of the LHC Dark Matter Working Group: Comparing LHC searches for dark matter mediators in visible and invisible decay channels and calculations of the thermal relic density

49. Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies

50. Immunotherapy Adverse Events

Catalog

Books, media, physical & digital resources